Awoniyi C A, Zirkin B R, Chandrashekar V, Schlaff W D
Department of Obstetrics and Gynecology, University of Colorado Health Sciences Center, Denver 80262.
Endocrinology. 1992 Jun;130(6):3283-8. doi: 10.1210/endo.130.6.1597140.
The administration of testosterone via Silastic capsules has been shown previously to maintain advanced spermatid number quantitatively in intact rats in which LH but not FSH was suppressed, but not in hypophysectomized rats, indicating that pituitary factors in addition to LH are required for the quantitative maintenance of spermatogenesis in the rat. The objective of the present study was to examine whether testosterone is capable of maintaining quantitatively normal spermatogenesis in rats in which both LH and FSH are suppressed. Intact adult male rats were actively immunized against GnRH by intradermal injection of GnRH conjugated to human serum globulin; control rats received intradermal injections of saline and adjuvant. Four weeks after the primary immunization, GnRH-immunized rats received the first booster injection and, at the same time, received testosterone-filled polydimethylsiloxane (PDS) implants of 4, 8, 12, or 24 cm or empty implants. Booster injections were repeated every 2 weeks for 8 weeks. At that time, rats were killed, and serum levels of LH, FSH, and testosterone, testicular advanced spermatid number, and seminiferous tubule fluid testosterone concentrations were determined. Four weeks after the initial administration of GnRH immunogen, i.e. before the first booster injection, serum levels of testosterone, LH, and FSH and the number of advanced spermatids per testis were not different from those in controls. Eight weeks after the first booster injection, serum LH and FSH and advanced spermatids were undetectable in all GnRH-immunized rats. The administration of testosterone-filled PDS implants of 4 and 8 cm to GnRH-immunized rats for 8 weeks resulted in the maintenance of 105 +/- 6 and 161 +/- 5 x 10(6) advanced spermatid/testis, respectively, significantly less than the control value (237 +/- 19 x 10(6)). In GnRH-immunized rats that received testosterone-filled PDS implants of 12 or 24 cm, the advanced spermatid numbers per testis (228 +/- 4 and 229 +/- 8 x 10(6), respectively) were not significantly different from those in controls. These results indicate that testosterone is capable of maintaining spermatogenesis quantitatively in the adult rats testis, in the absence of both radioimmunoassayable LH and FSH.
先前研究表明,通过硅橡胶胶囊给予睾酮,可使促黄体生成素(LH)受到抑制但促卵泡生成素(FSH)未受抑制的成年大鼠的晚期精子细胞数量在数量上维持在正常水平,但对垂体切除的大鼠则无此作用,这表明除LH外,大鼠精子发生的定量维持还需要垂体因子。本研究的目的是检验在LH和FSH均受抑制的大鼠中,睾酮是否能够在数量上维持正常的精子发生。通过皮内注射与人血清球蛋白偶联的促性腺激素释放激素(GnRH)对成年雄性大鼠进行主动免疫;对照大鼠接受皮内注射生理盐水和佐剂。初次免疫4周后,GnRH免疫大鼠接受首次加强注射,同时植入4、8、12或24厘米含睾酮的聚二甲基硅氧烷(PDS)植入物或空植入物。每2周重复加强注射,共8周。此时,处死大鼠,测定血清LH、FSH和睾酮水平、睾丸晚期精子细胞数量以及生精小管液睾酮浓度。在初次给予GnRH免疫原4周后,即首次加强注射前,睾酮、LH和FSH的血清水平以及每个睾丸的晚期精子细胞数量与对照组无差异。首次加强注射8周后,所有GnRH免疫大鼠的血清LH、FSH和晚期精子细胞均检测不到。对GnRH免疫大鼠给予4厘米和8厘米含睾酮的PDS植入物8周,分别使晚期精子细胞维持在105±6和161±5×10⁶/睾丸,显著低于对照值(237±19×10⁶)。在接受12厘米或24厘米含睾酮的PDS植入物的GnRH免疫大鼠中,每个睾丸的晚期精子细胞数量(分别为228±4和229±8×10⁶)与对照组无显著差异。这些结果表明,在既无可通过放射免疫测定的LH也无FSH的情况下,睾酮能够在数量上维持成年大鼠睾丸的精子发生。